FDA recall, , Moderate risk
Ocular Plus and Vista MAX Dietary Supplements
Ocular Plus and Vista MAX dietary supplements contain undeclared Yellow#5.
Summary by Recall Canary from the FDA notice
What happened
Provision Health Corp. dba PH Labs, of San Diego, California, recalled Vista MAX and Ocular Plus with Lutein dietary supplements because they contain undeclared Yellow#5. The recall began June 18, 2026, and was added to the FDA's Enforcement Report on July 1, 2026. The products were distributed to two local retail stores selling vitamins and health products.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for food recalls:
- Return it to the store where you bought it, or throw it away.
- Don't give it to anyone else, such as a food bank, or to a pet.
Is yours affected?
2 products
Affected if its lot code is listed.
Ocular Plus with Lutein, Zeaxanthin, and Omega 3-6-9; Dietary Supplement, 200 Capsules. Serving Size: 4 Capsules; Distributed by: L.A. Farmacia Natural, Burbank, CA 91504 UPC: PHF-C023
Reason: Dietary supplement product Ocular Plus contains undeclared Yellow#5.
- Lot code
- 509011
Vista MAX; Dietary Supplement, 90 Capsules. Serving Size: 4 Capsules; Distributed by: Vision of Health, Bell, CA 90201 UPC: PHF-C023
Reason: Dietary supplement product Vista MAX contains undeclared Yellow#5.
- Lot code
- 509011
Recall details
- Company began the recall
- Sold in
Product was distributed to two local direct accounts. Both are local retail stores selling various vitamins and health products.
- Company
- Provision Health Corp. dba PH LabsSan Diego, California
- Risk
Moderate risk
Eating it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99294
- Recall numbers
- H-1134-2026 to H-1135-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
